研究单位:[1]GuangZhou WeiShiBo Biotechnology Co., ltd[2]Beijing Tongren Hospital,Beijing,China,BJ10[3]The First Affiliated Hospital of Guangzhou University of traditional Chinese Medicine,Guangzhou,Guangdong,China,510030
The purpose of this study is to assess the primary safety and efficacy of High Myopic Posterior Scleral Fixation System in the treatment of macular schisis caused by high myopia.